Replies to post #442721 on NorthWest Biotherapeutics Inc (NWBO)

[ccie1024]

ae kusterer Wednesday, 02/09/22 08:23:05 PM
Re: None 0
Post # of 442721

flipper44 Member Level Wednesday, 02/09/22 05:35:00 PM
Re: None 0.010
Post #
442687
of 442720
Very Recent (Different) Patent Application Action. Forwarded to examiner February 2, 2022. Strange order of dates, that’s why I previously missed it. If memory serves, this application is essentially the same as the Canadien patent that was just granted up North.

Application number: 15/759699

Quote:
Skip to Main Content 15/759,699 METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS AND IMMUNOTHERAPEUTIC TREATMENTS FOR SUBJECTS WITH ADVANCED CANCERS 2943-P90US.PNP Printer Friendly Version
Select New Case Application Data Transaction History Image File Wrapper Continuity Data Published Documents Correspondence Data Assignments Display Download References
Transaction History
Date Transaction Description
11-25-2020 Electronic Information Disclosure Statement
04-17-2020 PTA statement filed under PTA1.704(d) with IDS
11-08-2019 PTA statement filed under PTA1.704(d) with IDS
[url][/url][tag]insert-text-here[/tag]01-28-2022 Electronic Information Disclosure Statement
[color


02-01-2022 Date Forwarded to Examiner
01-28-2022 Request for Continued Examination (RCE)
02-01-2022 Disposal for a RCE / CPA / R129
01-28-2022 Request for Extension of Time - Granted
01-28-2022 Information Disclosure Statement (IDS) Filed
01-28-2022 Workflow - Request for RCE - Begin


Lykiri Wednesday, 02/09/22 06:24:34 PM
Re: None 0
Post #
442705
of 442721
Webinar on Wednesday 9th February.

Moving towards digital supply chain management for GMP manufacturing.

Featuring insights from Kwok Pang, COO @autolomous and Daniel Baston @CGTCatapult.
https://buff.ly/3grt29h

InvestorsHub Ne